Full Committee Hearing

Implementing the Medicare Prescription Drug Benefit and Medicare Advantage Program: Perspectives on the Proposed Rules

Date: Tuesday, September 14, 2004 Time: 10:00 AM Location: 215 Dirksen Senate Office Building

There was no video broadcast for this event.

Member Statements

  1.  Chuck Grassley (R - IA)
  2. Senator Max Baucus (D - MT)

Witnesses

Panel I

  1. The Honorable Mark McClellan, M.D., Ph.D.
    Administrator, Centers for Medicare and Medicaid
    United States Department of Health and Human Services
    Washington , DC

Panel II

  1. Karen Ignagni
    President and CEO
    America's Health Insurance Plan
    Washington , DC
  2. Mark Merritt
    President & CEO
    Pharmaceutical Care Management Association
    Washington , DC
  3. Michael Fitzpatrick, M.S.W.
    Executive Director
    National Alliance for the Mentally Ill
    Arlington , VA
  4. Gerald Shea
    Assistant to the President for Governmental Affairs
    AFL-CIO
    Washington , DC
  5. Larry Burton
    Executive Director
    Business Roundtable
    Washington , DC

Related Files

Implementing the Medicare Prescription Drug Benefit and Medicare Advantage Program: Perspectives on the Proposed Rules

 How do I submit a statement for the record?

Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing.

Statements can be emailed to:

Statementsfortherecord@finance.senate.gov

Statements should be mailed (not faxed) to:

Senate Committee on Finance
Attn. Editorial and Document Section
Rm. SD-219
Dirksen Senate Office Bldg.
Washington, DC 20510-6200